VIREAD

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Nigeria, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug VIREAD contains one active pharmaceutical ingredient (API):

1	Tenofovir disoproxil UNII OTT9J7900I - TENOFOVIR DISOPROXIL FUMARATE
	Tenofovir disoproxil is absorbed and converted to the active substance tenofovir, which is a nucleoside monophosphate analogue. Tenofovir is then converted to the active metabolite, tenofovir diphosphate, an obligate chain terminator, by constitutively expressed cellular enzymes. Tenofovir diphosphate inhibits HIV-1 reverse transcriptase and the HBV polymerase by direct binding competition with the natural deoxyribonucleotide substrate and, after incorporation into DNA, by DNA chain termination.
	Read more about Tenofovir disoproxil

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VIREAD Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J05AF07	Tenofovir disoproxil	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
Discover more medicines within J05AF07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10310P, 11992E
BR	Câmara de Regulação do Mercado de Medicamentos	546820020000517
CA	Health Products and Food Branch	02247128
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00567592, 02089470, 02847485, 05013208, 05046834, 05373438, 05373444, 05387386, 06432858, 06432864, 07240546, 09927081, 10532962, 10532979, 10557560, 10757448, 10974341, 11095452, 11554368, 11554374, 12506207, 13569138, 13829970, 16008966, 16008972, 16259958, 16259964
EE	Ravimiamet	1196513, 1365184, 1602234, 1602245, 1602627, 1602638, 1602739, 1602740, 1602841
ES	Centro de información online de medicamentos de la AEMPS	01200001, 101200003, 101200004, 101200006, 101200008
FI	Lääkealan turvallisuus- ja kehittämiskeskus	009679, 067642, 175826, 451326, 477212
FR	Base de données publique des médicaments	60493359, 64593008, 67279692, 68718936, 69841906
GB	Medicines & Healthcare Products Regulatory Agency	220163, 220166, 220170, 220177, 33863
HK	Department of Health Drug Office	56075, 57750
IE	Health Products Regulatory Authority	88408
IL	מִשְׂרַד הַבְּרִיאוּת	4727
IT	Agenzia del Farmaco	035565011, 035565023, 035565035, 035565047, 035565050, 035565062, 035565074, 035565086, 035565098
JP	医薬品医療機器総合機構	6250024F1021
LT	Valstybinė vaistų kontrolės tarnyba	1031183, 1064334, 1068567, 1068568, 1068569, 1068570, 1068571, 1068572, 1068573
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	490M2004
NG	Registered Drug Product Database	04-9027
NL	Z-Index G-Standaard, PRK	146595, 146609, 146617, 146625, 146633
PL	Rejestru Produktów Leczniczych	100127594, 100313836, 100313859, 100313871, 100313888
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W51800001, W51800002
SG	Health Sciences Authority	13938P
TR	İlaç ve Tıbbi Cihaz Kurumu	8698760090014
US	FDA, National Drug Code	50090-0754, 61958-0401, 61958-0403, 61958-0404, 61958-0405, 61958-0406
ZA	Health Products Regulatory Authority	A40/20.2.8/0681